MFS
Mirabella Financial Services Portfolio holdings
AUM
$953M
1-Year Return
26.75%
This Quarter Return
+9.82%
1 Year Return
+26.75%
3 Year Return
+90.29%
5 Year Return
+169.53%
10 Year Return
–
AUM
$1.12B
AUM Growth
+$159M
(+17%)
Cap. Flow
+$15.5M
Cap. Flow
% of AUM
1.38%
Top 10 Holdings %
Top 10 Hldgs %
53.99%
Holding
557
New
244
Increased
61
Reduced
69
Closed
178
Top Buys
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$45.7M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$36.1M |
| 3 |
Energy Select Sector SPDR Fund
XLE
|
+$15.2M |
| 4 |
SPDR S&P Health Care Equipment ETF
XHE
|
+$10.6M |
| 5 |
Avista
AVA
|
+$10.5M |
Top Sells
| 1 |
Industrial Select Sector SPDR Fund
XLI
|
+$44M |
| 2 |
Frontline
FRO
|
+$39.8M |
| 3 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$34.1M |
| 4 |
Global X FinTech ETF
FINX
|
+$25.6M |
| 5 |
GOGL
Golden Ocean Group
GOGL
|
+$24.2M |
Sector Composition
| 1 | Healthcare | 12.42% |
| 2 | Industrials | 8.34% |
| 3 | Technology | 4.84% |
| 4 | Consumer Discretionary | 2.67% |
| 5 | Utilities | 2.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Lowe's Companies
LOW
$151B
| $200K | 0.02% |
+1,004
| New | +$200K |
|
327
Opendoor
OPEN
$4.5B
| $190K | 0.02% |
163,913
+103,107
| +170% | +$120K |
|
328
Viking Therapeutics
VKTX
$2.84B
| $190K | 0.02% |
+20,178
| New | +$190K |
|
329
Dana Inc
DAN
$2.7B
| $174K | 0.02% |
11,499
-2,532
| -18% | -$38.3K |
|
|
AVEO
330
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $167K | 0.01% |
+11,154
| New | +$167K |
|
|
CBAY
331
DELISTED
Cymabay Therapeutics
CBAY
| $156K | 0.01% |
+24,873
| New | +$156K |
|
332
Compass Therapeutics
CMPX
$597M
| $153K | 0.01% |
+30,444
| New | +$153K |
|
|
ALLK
333
DELISTED
Allakos
ALLK
| $153K | 0.01% |
+18,172
| New | +$153K |
|
334
Aldeyra Therapeutics
ALDX
$346M
| $145K | 0.01% |
+20,858
| New | +$145K |
|
335
Oramed Pharmaceuticals
ORMP
$94.7M
| $144K | 0.01% |
+11,974
| New | +$144K |
|
336
Viemed Healthcare
VMD
$260M
| $143K | 0.01% |
+18,941
| New | +$143K |
|
337
Medical Properties Trust
MPW
$2.77B
| $143K | 0.01% |
+12,853
| New | +$143K |
|
338
Pebblebrook Hotel Trust
PEB
$1.36B
| $142K | 0.01% |
+10,608
| New | +$142K |
|
339
Norwegian Cruise Line
NCLH
$11.5B
| $133K | 0.01% |
10,832
-5,360
| -33% | -$65.6K |
|
340
Scholar Rock
SRRK
$3.04B
| $125K | 0.01% |
+13,765
| New | +$125K |
|
341
Wave Life Sciences
WVE
$1.19B
| $124K | 0.01% |
+17,661
| New | +$124K |
|
|
APEN
342
DELISTED
Apollo Endosurgery, Inc.
APEN
| $121K | 0.01% |
+12,120
| New | +$121K |
|
343
Ardelyx
ARDX
$1.58B
| $106K | 0.01% |
+37,193
| New | +$106K |
|
344
BioAtla
BCAB
$41.9M
| $99.4K | 0.01% |
+12,044
| New | +$99.4K |
|
|
PSTX
345
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $97.4K | 0.01% |
+18,385
| New | +$97.4K |
|
346
Prelude Therapeutics
PRLD
$67.4M
| $97K | 0.01% |
+16,058
| New | +$97K |
|
347
ARS Pharmaceuticals
SPRY
$1.02B
| $90.2K | 0.01% |
+10,573
| New | +$90.2K |
|
|
CNCE
348
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $90K | 0.01% |
+15,410
| New | +$90K |
|
349
ClearPoint Neuro
CLPT
$311M
| $87.5K | 0.01% |
+10,328
| New | +$87.5K |
|
350
Lineage Cell Therapeutics
LCTX
$290M
| $86.7K | 0.01% |
+74,065
| New | +$86.7K |
|